To make a conclusion, our data has clarified that CFE exhibits suppressive effects against HCC both in cellular and animal models, and inhibiting the Apelin/APJ system contributes to the anti-HCC mechanisms of CFE. The gene discussed is APLNR; the disease is hepatocellular carcinoma.